Biomedical Engineering Reference
In-Depth Information
36. Verbeken EK, Cauberghs M, Mertens I, Lauweryns JM, Van de Woestijne KP.
Tissue and airway impedance of excised normal, senile, and emphysematous
lungs. J Appl Physiol 1992; 72:2343-2353.
37. Yanai M, Sekizawa K, Ohrui T, Sasaki H, Takishima T. Site of airway obstruc-
tion in pulmonary disease: direct measurement of intrabronchial pressure. J
Appl Physiol 1992; 72:1016-1023.
38. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med
J 1977; 1:1645-1648.
39. Peto R, Speizer FE, Cochrane AL, Moore F, Fletcher CM, Tinker CM,
Higgins IT, Gray RG, Richards SM, Gilliland J, Norman-Smith B. The rele-
vance in adults of air-flow obstruction, but not of mucus hypersecretion, to
mortality from chronic lung disease. Results from 20 years of prospective
observation. Am Rev Respir Dis 1983; 128:491-500.
40. Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion
with FEV1 decline and chronic obstructive pulmonary disease morbidity.
Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996;
153:1530-1535.
41. Vestbo J. Epidemiological studies in mucus hypersecretion. Novartis Found
Symp 2002; 248:3-12.
42. Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote
FEV(l) decline in current smokers but not ex-smokers with mild chronic
obstructive pulmonary disease: results from the lung health study. Am J Respir
Crit Care Med 2001; 164:358-364.
43. Saetta M, Turato G, Facchini FM, Corbino L, Lucchini RE, Casoni G,
Maestrelli P, Mapp CE, Ciaccia A, Fabbri LM. Inflammatory cells in the bron-
chial glands of smokers with chronic bronchitis. Am J Respir Crit Care Med
1997; 156:1633-1639.
44. Zhu J, Majumdar S, Qiu Y, Ansari T, Oliva A, Kips JC, Pauwels RA, De Rose
V, Jeffery PK. Interleukin-4 and interleukin-5 gene expression and inflamma-
tion in the mucus-secreting glands and subepithelial tissue of smokers with
chronic bronchitis. Lack of relationship with CD8(
รพ
) cells. Am J Respir Crit
Care Med 2001; 164:2220-2228.
45. Sommerhoff CP, Nadel JA, Basbaum CB, Caughey GH. Neutrophil elastase
and cathepsin G stimulate secretion from cultured bovine airway gland serous
cells. J Clin Invest 1990; 85:682-689.
46. Sommerhoff CP, Caughey GH, Finkbeiner WE, Lazarus SC, Basbaum CB,
Nadel JA. Mast cell chymase: a potent secretagogue for airway gland serous
cells. J Immunol 1989; 142:2450-2455.
47. Witko-Sarsat V, Halbwachs-Mecarelli L, Schuster A, Nusbaum P, Ueki I,
Canteloup S, Lenoir G, Descamps-Latscha B, Nadel JA. Proteinase 3, a potent
secretagogue in airways, is present in cystic fibrosis sputum. Am J Respir Cell
Mol Biol 1999; 20:729-736.
48. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Relation of ventilatory
impairment and of chronic mucus hypersecretion to mortality from obstructive
lung disease and from all causes. Thorax 1990; 45:579-585.
49. Miravitlles M, Guerrero T, Mayordomo C, Sanchez-Agudo L, Nicolau F, Segu
JL. Factors associated with increased risk of exacerbation and hospital admis-
